These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 13361428)

  • 21. [STUDY OF BOTULINUM TOXOIDS. VI. TYPE D BOTULINUM TOXOID].
    VOROBEV AA; VASILEV NN; SHEVELEV VM; VORONOVA ZA; PETROVA EK; BAZHENOVA GA; ANDROSHCHUK SM
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Sep; 40():87-92. PubMed ID: 14119975
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of heat upon diphtheria toxoid-antitoxin floccules.
    BARR M
    Br J Exp Pathol; 1949 Feb; 30(1):61-72. PubMed ID: 18128096
    [No Abstract]   [Full Text] [Related]  

  • 23. Clostridium botulinum types A and B toxin-antitoxin reactions.
    FULTHORPE AJ
    J Hyg (Lond); 1955 Jun; 53(2):180-95. PubMed ID: 14392316
    [No Abstract]   [Full Text] [Related]  

  • 24. [THE SIGNIFICANCE OF TYPE E BOTULINUM TOXIN ACTIVATION IN THE LABORATORY DIAGNOSIS OF BOTULISM].
    BULATOVA TI
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Aug; 41():97-101. PubMed ID: 14255908
    [No Abstract]   [Full Text] [Related]  

  • 25. The purification and crystallization of Clostridium botulinum type A toxin.
    LAMANNA C; McELROY OE; EKLUND HW
    Science; 1946 May; 103(2681):613. PubMed ID: 21026141
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical Study of New Tetravalent (Type A, B, E, and F) Botulinum Toxoid Vaccine Derived from M Toxin in Japan.
    Torii Y; Sugimoto N; Kohda T; Kozaki S; Morokuma K; Horikawa Y; Ginnaga A; Yamamoto A; Takahashi M
    Jpn J Infect Dis; 2017 Jul; 70(4):423-429. PubMed ID: 28250257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of the kinetics of detoxication of purified botulinum type A toxin by formol.
    VASIL'EV NN
    Biokhimiia; 1962; 26():587-91. PubMed ID: 14039966
    [No Abstract]   [Full Text] [Related]  

  • 28. Qualitative differences among toxins and toxoids.
    BARR M; GLENNY AT
    J Hyg (Lond); 1949 Jun; 47(2):107-14. PubMed ID: 15392610
    [No Abstract]   [Full Text] [Related]  

  • 29. Development and preclinical evaluation of a new F(ab')₂ antitoxin against botulinum neurotoxin serotype A.
    Yu YZ; Zhang SM; Wang WB; Du Y; Zhu HQ; Wang RL; Zhou XW; Lin JB; Wang S; Yu WY; Huang PT; Sun ZW
    Biochimie; 2010 Oct; 92(10):1315-20. PubMed ID: 20600570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serological studies of types A, B, and E botulinal toxins by passive hemagglutination and bentonite flocculation.
    Johnson HM; Brenner K; Angelotti R; Hall HE
    J Bacteriol; 1966 Mar; 91(3):967-74. PubMed ID: 5326104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxoid of Clostridium botulinum type F: purification and immunogenicity studies.
    Hatheway CL
    Appl Environ Microbiol; 1976 Feb; 31(2):234-42. PubMed ID: 793522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on botulinum toxoid, types A and P; production of alum precipitated toxoids.
    NIGG C; HOTTLE GA
    J Immunol; 1947 Mar; 55(3):245-54. PubMed ID: 20288108
    [No Abstract]   [Full Text] [Related]  

  • 33. The alpha antitoxin content of the international reference preparations of Clostridium welchii types B and D antitoxins.
    SKULBERG A; VAN HEYNINGEN WE
    Bull World Health Organ; 1956; 14(3):557-66. PubMed ID: 13342930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of Clostridium botulinum toxoids. I. Type A Clostridium botulinum toxoid.
    VOROB'EV AA; VASIL'EV NN; PATRIKEYEV GT; ZYBIN VD; SHMELEV VM; KORNEV IS; ANAN'EVA EP
    Zh Mikrobiol Epidemiol Immunobiol; 1961; 32():1601-8. PubMed ID: 14040099
    [No Abstract]   [Full Text] [Related]  

  • 35. [DETECTION OF BOTULISM TOXINS AND MICROBES OF B AND C TYPES IN THE BODIES OF SICK HUMAN AND ANIMAL SUBJECTS AND IN CADAVERS].
    SERGEEVA TI
    Zh Mikrobiol Epidemiol Immunobiol; 1963 Jul; 40():77-82. PubMed ID: 14070208
    [No Abstract]   [Full Text] [Related]  

  • 36. A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins.
    Barash JR; Arnon SS
    J Infect Dis; 2014 Jan; 209(2):183-91. PubMed ID: 24106296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on immunity to toxins of Clostridium botulinum. VIII. Immunological response of man to purified bivalent AB botulinum toxoid.
    FIOCK MA; DEVINE LF; GEARINGER NF; DUFF JT; WRIGHT GG; KADULL PJ
    J Immunol; 1962 Mar; 88():277-83. PubMed ID: 13893049
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of the reaction of indirect hemagglutination in the determination of botulin toxin in sausage products].
    IAFAEV RKh; CHEPELEV SA
    Zh Mikrobiol Epidemiol Immunobiol; 1961 Nov; 32():21-5. PubMed ID: 14450367
    [No Abstract]   [Full Text] [Related]  

  • 39. Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities.
    Dembek ZF; Smith LA; Rusnak JM
    Disaster Med Public Health Prep; 2007 Nov; 1(2):122-34. PubMed ID: 18388640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intoxication of botulinum toxin].
    Chudzicka A
    Pol Merkur Lekarski; 2015 Sep; 39(231):153-6. PubMed ID: 26449577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.